Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics
- PMID: 32823619
- PMCID: PMC7565412
- DOI: 10.3390/medsci8030032
Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics
Abstract
Background: Urinary tract infections (UTIs) are major healthcare problems that are usually treated empirically. However, antimicrobial resistance has been increasing across many settings. This study aims to elucidate the antibiotic resistance profiles of three common uropathogens, Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), and Proteus mirabilis (P. mirabilis) and compare between extended spectrum beta-lactamase (ESBL) and non-ESBL strains among Lebanese patients. Methods: This retrospective study was conducted at multiple tertiary healthcare centers in South Lebanon, between January and September 2017, including 551 patients of all age groups. Demographic, clinical, and laboratory data of patients were collected and analyzed statistically. Results: The prevalence of UTI in Lebanon was highest in adults between 19 and 64 years (44%). E. coli was the predominant uropathogenic organism (67.1%) followed by K. pneumoniae (10%) and P. mirabilis (3.7%). ESBL represented 32.9% of the UTI agents. The three common uropathogens studied were found to be most susceptible to imipenem (100%) and meropenem (100%). Interestingly, 115 (25.1%) out of the 458 E. coli isolates were resistant to more than eight antibiotics while 107 (23.4%) were susceptible to all antibiotics studied. Conclusions: Our study underlined the importance of adequate antimicrobial prescription for UTIs in Lebanon to avoid multidrug resistance.
Keywords: ESBL; Escherichia coli; Lebanon; antimicrobial susceptibilities; urinary tract infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31. Int Urol Nephrol. 2015. PMID: 26026972
-
Spectrum and patterns of antimicrobial resistance of uropathogens isolated from a sample of hospitalised Lebanese patients with urinary tract infections.J Glob Antimicrob Resist. 2014 Sep;2(3):173-178. doi: 10.1016/j.jgar.2014.01.007. Epub 2014 Mar 28. J Glob Antimicrob Resist. 2014. PMID: 27873725
-
Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.J Med Microbiol. 2014 Apr;63(Pt 4):556-561. doi: 10.1099/jmm.0.068981-0. Epub 2014 Jan 29. J Med Microbiol. 2014. PMID: 24478449
-
Urinary Tract Infections: The Current Scenario and Future Prospects.Pathogens. 2023 Apr 20;12(4):623. doi: 10.3390/pathogens12040623. Pathogens. 2023. PMID: 37111509 Free PMC article. Review.
-
Antimicrobial Activity of Spices Popularly Used in Mexico against Urinary Tract Infections.Antibiotics (Basel). 2023 Feb 3;12(2):325. doi: 10.3390/antibiotics12020325. Antibiotics (Basel). 2023. PMID: 36830236 Free PMC article. Review.
Cited by
-
What Doesn't Kill Them Makes Them Stronger: The Impact of the Resistance Patterns of Urinary Enterobacterales Isolates in Patients from a Tertiary Hospital in Eastern Europe.Antibiotics (Basel). 2022 Apr 20;11(5):548. doi: 10.3390/antibiotics11050548. Antibiotics (Basel). 2022. PMID: 35625192 Free PMC article.
-
Prevalence and Clinical Significance of Urinary Tract Infection among Neonates Presenting with Unexplained Hyperbilirubinemia in Lebanon: A Retrospective Study.Infect Chemother. 2023 Jun;55(2):194-203. doi: 10.3947/ic.2022.0117. Infect Chemother. 2023. PMID: 37407240 Free PMC article.
-
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic Escherichia coli in Western Saudi Arabia.Pol J Microbiol. 2022 Sep 2;71(3):325-339. doi: 10.33073/pjm-2022-029. eCollection 2022 Sep 1. Pol J Microbiol. 2022. PMID: 36048880 Free PMC article.
-
Assessment of community-acquired urinary tract infections treatment in the emergency department: a retrospective study.Front Cell Infect Microbiol. 2024 Oct 16;14:1433597. doi: 10.3389/fcimb.2024.1433597. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39479280 Free PMC article.
-
Low yield but high levels of multidrug resistance in urinary tract infections in a tertiary hospital, Nepal.Public Health Action. 2021 Nov 1;11(Suppl 1):70-76. doi: 10.5588/pha.21.0044. Public Health Action. 2021. PMID: 34778019 Free PMC article.
References
-
- Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. An Off. Publ. Infect. Dis. Soc. Am. 1992;15(Suppl. 1):S216–S227. doi: 10.1093/clind/15.Supplement_1.S216. - DOI - PubMed
LinkOut - more resources
Full Text Sources